REG - Venture Life Group - Exercise of Share Options & Voting Rights

Venture LifeAnnouncement

10/05/2022 11:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220510:nRSJ9509Ka&default-theme=true

RNS Number : 9509K  Venture Life Group PLC  10 May 2022

10 May 2022

Venture Life Group plc

("Venture Life" or the "Company")

Exercise of Share Options & Voting Rights

 

Venture Life (AIM: VLG), a leading developer, manufacturer and distributer of
consumer self-care products, announces that is has issued 666,667 ordinary
shares of 0.3 pence each in the capital of the Company ("Ordinary Shares") in
accordance with an exercise of employee share options, subject to Admission to
trading on AIM.

Application will be made to the London Stock Exchange for the 666,667 new
Ordinary Shares to be admitted to trading on AIM ("Admission") and it is
expected that Admission will become effective and trading will commence at
8.00 a.m. on 13 May 2022.

Following Admission, the total number of Ordinary Shares in issue will be
126,498,197 and the total number of voting rights will therefore be
126,498,197. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

Venture Life Group PLC
 
          +44 (0) 1344 578004

Jerry Randall, Chief Executive Officer

Daniel Wells, Chief Financial Officer

 

Cenkos Securities plc (Nomad and Joint
Broker)
                +44 (0) 20 7397 8900

Stephen Keys / Camilla Hume (Corporate Finance)

Russell Kerr / Michael Johnson (Sales)

 

Singer Capital Markets (Joint Broker)

Shaun Dobson / Alaina Wong  (Corporate Finance)
 
+44 (0) 20 74963000

Jonathan Dighe (Sales)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TVREAESEFDEAEFA